|Bid||379.02 x 800|
|Ask||387.74 x 1000|
|Day's range||379.13 - 384.64|
|52-week range||217.03 - 401.78|
|Beta (5Y monthly)||0.66|
|PE ratio (TTM)||26.84|
|Forward dividend & yield||2.16 (0.57%)|
|Ex-dividend date||30 Nov 2022|
|1y target est||N/A|
Outperforming the Zacks Oils and Energy sector in 2022 is no easy task. However, bulls have silently roamed in all three of these stocks, breaking the overall bearish trend we've become accustomed to.
Henry Schein's (HSIC) recent deal with VideaHealth is expected to aid dentists in proving greater transparency to patients, thus making better treatment recommendations and improving case acceptance.
Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.